Evidence map›Paper›PMID 41749783›Full record

ArticleBioengineering (Basel, Switzerland)2026

Synthetic Melanoma Image Generation and Evaluation Using Generative Adversarial Networks.

Pei-Yu Lin, Yidan Shen, Neville Mathew, Renjie Hu, Siyu Huang, Courtney M Queen, Cameron E West, Ana Ciurea, George Zouridakis

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pei-Yu LinDepartment of Engineering Technology, University of Houston, Sugar Land, TX 77479, USA.ORCID 0009-0001-8166-2879
Yidan ShenDepartment of Electrical and Computer Engineering, University of Houston, Houston, TX 77204, USA.ORCID 0009-0005-8412-7854
Neville MathewDepartment of Engineering Technology, University of Houston, Sugar Land, TX 77479, USA.ORCID 0009-0000-3213-364X
Renjie HuDepartment of Information Science Technology, University of Houston, Sugar Land, TX 77479, USA.ORCID 0000-0002-0496-6035
Siyu HuangSchool of Computing, Clemson University, Clemson, SC 29634, USA.
Courtney M QueenDepartment of Public Health, Texas Tech University, Abilene, TX 79601, USA.ORCID 0000-0001-6615-9389
Cameron E WestDepartment of Dermatology and Pathology, Texas Tech University, Abilene, TX 79601, USA.ORCID 0000-0001-9673-9165
Ana CiureaDepartment of Dermatology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0003-2685-9430
George ZouridakisDepartment of Engineering Technology, University of Houston, Sugar Land, TX 77479, USA.ORCID 0000-0002-7770-9857

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma is the most lethal form of skin cancer, and early detection is critical for improving patient outcomes. Although dermoscopy combined with deep learning has advanced automated skin-lesion analysis, progress is hindered by limited access to large, well-annotated datasets and by severe class imbalance, where melanoma images are substantially underrepresented. To address these challenges, we present the first systematic benchmarking study comparing four GAN architectures-DCGAN, StyleGAN2, and two StyleGAN3 variants (T and R)-for high-resolution (512×512) melanoma-specific synthesis. We train and optimize all models on two expert-annotated benchmarks (ISIC 2018 and ISIC 2020) under unified preprocessing and hyperparameter exploration, with particular attention to R1 regularization tuning. Image quality is assessed through a multi-faceted protocol combining distribution-level metrics (FID), sample-level representativeness (FMD), qualitative dermoscopic inspection, downstream classification with a frozen EfficientNet-based melanoma detector, and independent evaluation by two board-certified dermatologists. StyleGAN2 achieves the best balance of quantitative performance and perceptual quality, attaining FID scores of 24.8 (ISIC 2018) and 7.96 (ISIC 2020) at γ=0.8. The frozen classifier recognizes 83% of StyleGAN2-generated images as melanoma, while dermatologists distinguish synthetic from real images at only 66.5% accuracy (chance = 50%), with low inter-rater agreement (κ=0.17). In a controlled augmentation experiment, adding synthetic melanoma images to address class imbalance improved melanoma detection AUC from 0.925 to 0.945 on a held-out real-image test set. These findings demonstrate that StyleGAN2-generated melanoma images preserve diagnostically relevant features and can provide a measurable benefit for mitigating class imbalance in melanoma-focused machine learning pipelines.

Indexed as

class imbalancegenerative adversarial networksimage synthesismelanomaskin cancer detectionsynthetic data

Identifiers

PMID41749783
PMCPMC12938608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.